First Header Logo Second Header Logo

Tildrakizumab: A Review of Phase II and III Clinical Trials.

Kolli SS, Gabros SD, Pona A, Cline A, Feldman SR. Tildrakizumab: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2019 04; 53(4):413-418.

View in: PubMed